• Feb 13, 2025

Goldman’s Rubner Sees US Stock Risk as Everybody ‘in the Pool’

(Bloomberg) -- A bearish trade is looming for US equities, according to Goldman Sachs Group Inc.’s Scott Rubner.The market is increasingly crowded and dip-buying is running out of steam, Rubner said. The managing director for global markets and tactical specialist was rightfully bullish heading into 2025, while touting an upcoming negative turn. In a note on Wednesday, he said this was his “last bullish email” for the first quarter.“Everyone is in the pool, including retail traders, 401k inflows

• Feb 13, 2025

Could Bitcoin Reach $200,000 in 2025?

It seems like any time the doubters claim that Bitcoin (CRYPTO: BTC) is dead, it simply bounces back to reach fresh all-time highs. This leading digital asset has soared in the past few years, but in the past seven weeks, it's been trading around the $100,000 level. Bitcoin bulls are hoping for the next breakout to happen.

• Feb 13, 2025

Some federal workers are ‘getting wealthy at taxpayer expense,’ says Elon Musk, whose companies have received at least $20 billion from the government

Musk’s task force wants to cut tens of thousands of federal workers, and now it’s aiming at people he thinks are too rich.

• Feb 12, 2025

Spanish travel technology group HBX slumps on market debut

Shares in Spanish travel technology company HBX Group plunged on their market debut on Thursday, erasing 236 million euros of its market value. HBX Group, which owns the Hotelbeds brand, had priced its shares at 11.50 euros earlier in the week for a 2.84 billion euro ($2.96 billion) valuation, in one of the euro zone's first initial public offerings of the year. The Madrid-listed shares, however, were down 8.3% at 10.54 euros by 0920 GMT while the blue-chip IBEX-35 index was unchanged.

• Feb 12, 2025

Spotting Winners: Penumbra (NYSE:PEN) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q3

Looking back on medical devices & supplies - cardiology, neurology, vascular stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Penumbra (NYSE:PEN) and its peers.

• Feb 12, 2025

Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Merit Medical Systems (NASDAQ:MMSI) Vs The Rest

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including Merit Medical Systems (NASDAQ:MMSI) and its peers.

• Feb 12, 2025

Q4 Earnings Review: Consumer Internet Stocks Led by Amazon (NASDAQ:AMZN)

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at consumer internet stocks, starting with Amazon (NASDAQ:AMZN).

• Feb 12, 2025

Senior Health, Home Health & Hospice Stocks Q3 Earnings Review: Option Care Health (NASDAQ:OPCH) Shines

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Option Care Health (NASDAQ:OPCH) and its peers.

• Feb 12, 2025

Reflecting On Online Marketplace Stocks’ Q3 Earnings: eBay (NASDAQ:EBAY)

Looking back on online marketplace stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including eBay (NASDAQ:EBAY) and its peers.

• Feb 12, 2025

ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at ANI Pharmaceuticals (NASDAQ:ANIP) and its peers.